FDA Approved: DACTINOMYCIN — Original Application (XGen Pharmaceuticals DJB, Inc.)

View source ↗

Summary

FDA approved the original (ANDA) application for Dactinomycin from XGen Pharmaceuticals DJB, Inc., establishing a generic version of this chemotherapy agent. Da…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Gestational Trophoblastic Neoplasia
• Rhabdomyosarcoma
• Wilms Tumor

Drugs mentioned

• Dactinomycin (dactinomycin)

Snippet

ORIG AP for DACTINOMYCIN (DACTINOMYCIN)